Finemost Corporation

CLOSEOUT LETTER Finemost Corporation February 15, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Recipient: Finemost Corporation United States Issuing Office: United States Office of Human and Animal Foods Division West 5 Los Angeles District Office 19701 Fairchild, Irvine CA Telephone: 949-608-2900 Fax: 949-608-4417 UNITED PARCEL SERVICE SIGNATURE REQUIRED February 15, 2018 Mr. Samuel S. Chang, CEO Finemost Corporation 13839 Bentley Place Cerritos, CA 90703 Dear Mr. Chang: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter [WL#32-13 issued March 20, 2013]. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Darla Bracy, District Director Office of Human and Animal Food Division 5 West Content current as of: 03/20/2018